Method for predicting recurrence probability of specific disease based on clustering method
By preprocessing and identifying patient disease data using clustering methods, and combining supervised clustering and machine learning algorithms, a recurrence probability prediction model is constructed. This solves the problem of insufficient accuracy in predicting disease recurrence in traditional methods, and achieves efficient and accurate recurrence probability prediction.
Patent Information
- Application Number
- CN202410933240.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-12
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-07-12
AI Technical Summary
Traditional methods for predicting disease recurrence probability rely on physician experience, lack data-driven and personalized approaches, and existing models fail to effectively consider changes in biomarkers, resulting in insufficient prediction accuracy and reliability.
Clustering methods were used to preprocess, segment, identify features, arrange and combine data, and stratify risk in patient disease data. A recurrence probability prediction model was constructed by combining supervised clustering and machine learning algorithms. Subgroups were divided based on EBV DNA level and tumor response. Graph autoencoder and K-means clustering were used to identify risk groups. Concordance index was calculated to assess prognostic performance.
It improves the accuracy and precision of disease recurrence probability prediction, realizes automated and real-time risk stratification prediction, adapts to the recurrence probability prediction needs of different standards and methods, saves resources, and improves work efficiency.
Smart Images

Figure CN118919054A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of prediction, and in particular to a prediction method for the recurrence probability of a specific disease based on a clustering method. Background Art
[0002] With the continuous development of medical technology and the continuous accumulation of medical data, the prediction of the probability of recurrence of a specific disease has become one of the hot topics in current medical research. Traditional prediction methods mostly rely on the doctor's experience and observation of the individual patient's condition. The accuracy and reliability of this method are limited by the doctor's subjective judgment, and it is difficult to achieve rapid analysis of a large amount of patient data.
[0003] In the past half century, great efforts have been made to elucidate the heterogeneity of NPC, but previous models did not consider changes in biomarkers during treatment, had relatively poor predictive effects, lacked external validation, and were unable to predict the benefit of AC.
[0004] As an unsupervised learning technique, clustering methods can identify patterns and structures in data without pre-labeling. In disease recurrence prediction, clustering can help discover patient subgroups that may have different recurrence risk characteristics. With the accumulation of medical data and the improvement of computing power, data-driven personalized medicine has become possible. By analyzing the multidimensional data of patients, including genome, transcriptome, proteome, metabolome, and clinical data, the probability of disease recurrence can be predicted more accurately. Summary of the invention
[0005] The object of the present invention is to provide a method for predicting the recurrence probability of a specific disease based on a clustering method.
[0006] To achieve the above object, the present invention is implemented according to the following technical solutions:
[0007] The present invention comprises the following steps:
[0008] Collecting disease data of patients at different periods and preprocessing the disease data of patients;
[0009] Dividing the patient's disease data according to EBV DNA levels and tumor response to obtain subgroup data, and performing feature identification on the subgroup data according to relative risk to obtain temporal disease features;
[0010] Arrange and combine the time series disease characteristics to obtain disease manifestation data, and use supervised clustering to perform risk stratification on the disease manifestation data to obtain risk groups;
[0011] The prognostic performance of the risk group is evaluated by the Concordia Index, and the prognostic performance is compared with the TNM staging to obtain recurrence data;
[0012] A recurrence probability prediction model is constructed according to the recurrence data, the data to be predicted is input into the recurrence probability prediction model, and a prediction result is output.
[0013] Further, the method for dividing the patient disease data according to EBV DNA level and tumor response includes:
[0014] The patient's tumor response is obtained through medical imaging and clinical examinations, and the EBV DNA level is obtained by extracting DNA from the patient's blood;
[0015] Calculate the disease factor:
[0016]
[0017] The disease factor at the tth moment is The DNA weight is λ1, the tumor weight is λ2, and the tumor response at the tth moment is The EBV DNA level at the tth moment is Standard tumor response was The standard EBV DNA level is The EBV DNA level at time t-1 is The tumor response at time t-1 is
[0018] When the disease factor is greater than zero and less than 0.27, the patient's disease data is divided into the first subgroup data; when the disease factor is greater than 0.27 and less than 0.48, the patient's disease data is divided into the second subgroup data; when the disease factor is greater than 0.48 and less than 0.77, the patient's disease data is divided into the third subgroup data; when the disease factor is greater than 0.77 and less than 1, the patient's disease data is divided into the fourth subgroup data.
[0019] Furthermore, the method of performing feature recognition on the subgroup data according to the relative risk to obtain the time series disease feature comprises:
[0020] The edge detection algorithm was used to extract the image features of the subgroup data, and the sliding window technique was used to segment the images in chronological order to obtain segment time series data;
[0021] Calculate the center point of a segment of time series data:
[0022]
[0023] The window size is m, and the time series data of the a+wth segment is d a+w , the center point of the wth segment of time series data is
[0024] Construct a dimension vector to formally represent the center point of the segment time series data. The expression is:
[0025]
[0026] The w-th d value of the i-th window is expressed as The wth segment time series data is d w , the w+1th segment time series data is d w+1 , the time series data of the w+m-1th segment is d w+m-1 ;
[0027] Calculate the similarity between vectors:
[0028]
[0029] The w+sth segment time series data of the i-th window is The w+sth segment time series data of the i+1th window is The center point of the wth segment of the time series data in the i-th window is The center point of the wth segment of the time series data in the i+1th window is The difference between the i-th window segment time series data and the z-th window segment time series data is h i,i+1 , segment timing data and segment timing data The deviation is η i,i+1 , similarity capacity parameter is ρ;
[0030] Calculate the change information between vectors:
[0031]
[0032] The segment time series data and segment timing data The change information degree is ε i,i+1 , the number of windows is p, the time series data and segment timing data The change in
[0033] Calculate relative risk:
[0034]
[0035] The relative risk between the i-th window and the z-th window is The scale factor is γ and the heritability coefficient is The initial error value is δ;
[0036] The windows with relative risk absolute values greater than 0.11 were taken as disease windows, and the segment time series data with dissimilarity distances greater than 0.27 within the disease windows were output as disease features.
[0037] Furthermore, the method of obtaining disease manifestation data by arranging and combining the disease characteristics includes:
[0038] Calculate the association of disease features:
[0039]
[0040] The correlation coefficient between disease feature j and disease feature f is θ jf , the probability of disease feature j and disease feature f appearing at the same time is c(j,f), and the probability of disease feature j appearing is c j , the probability of the characteristic disease f appearing is c f , the first weight is β1, and the second weight is β2;
[0041] According to the degree of association, the disease features are divided into associated feature sets, and the associated feature sets are randomly combined and output as disease manifestation data.
[0042] Furthermore, a method for risk stratifying the disease manifestation data using supervised clustering to obtain risk groups includes:
[0043] The disease manifestation data is input into a clustering model based on a graph autoencoder, where the clustering model includes an encoder network, a graph encoding network, and an adaptive fusion network;
[0044] K-means clustering was used to perform initial clustering on the disease manifestation data to obtain the initial cluster centers;
[0045] Given the transfer function of the encoder network and the transfer function of the graph encoding network, the expressions are:
[0046]
[0047] The bias vector of the encoder network layer κ is φ κ , the transfer function of the κ-1th layer of the encoder network is G κ-1 , the weight matrix of the encoder network layer κ is F κ , the activation function is The normalized adjacency matrix is Q * , the weight of the κ-1th layer of the graph encoding network is The transfer function of the κth layer of the graph coding network is S κ , the output of the κ-1th layer of the graph encoding network is S κ-1 , the transfer function of the κth layer of the encoder network is G κ ;
[0048] Calculate the propagation function of the first layer network:
[0049]
[0050] The learning rate is χ, and the weight matrix of the κth layer of the adaptive fusion network is The bias vector of the κth layer of the adaptive fusion network is The propagation function of the κth layer of the adaptive fusion network is W κ ;
[0051] Let κ = κ + 1, recalculate the transfer function of the encoder network, the transfer function of the graph encoding network, and calculate the transfer function of the adaptive fusion network:
[0052]
[0053] The transfer function of the κ-1th layer of the graph coding network is W κ-1 , calculate the loss function of the encoder network:
[0054]
[0055] The number of disease manifestation data is P, the output norm function is ‖·‖, the disease manifestation data is Q, and the reconstructed disease manifestation data is V * , the loss function of the computational graph encoding network is:
[0056]
[0057] Calculate the encoder divergence:
[0058]
[0059] The encoder network disease manifestation data k g and the initial cluster center u h The probability distribution of The hth initial cluster center is u h , encoder network disease manifestation data k g and the initial cluster center u h The high confidence distribution of The g-th disease manifestation data is k g , the degrees of freedom are The adjustment factor is σ, and the divergence of the encoder network is L gh ;
[0060] Compute the divergence of the graph encoding network:
[0061]
[0062] The heritability coefficient is ζ2, the deviation factor is λ, and the graph encoding network disease expression data kg and the initial cluster center u h The probability distribution of The divergence of the graph coding network is L gh ;
[0063] Calculate the loss function of the clustering model:
[0064]
[0065] The graph weight is α, the divergence weight is μ, and the cluster center is The clustering data is y, and the disease manifestation data is k g and the initial cluster center u h The probability distribution is r gh ;
[0066] Update the weight matrix, bias vector, and learning rate through back-propagation until the maximum number of iterations is reached, otherwise update the transfer function;
[0067] The clustering results are obtained through collaborative training and output as risk groups.
[0068] Further, the method for evaluating the prognostic performance of the risk group by the Concordia Index comprises:
[0069] Machine learning algorithms are used to predict the survival probability and time of the risk group and calculate the concordance index of the risk group:
[0070]
[0071] The concord index is The indicator function is K(·), and the survival time of patient a is T a , the survival time of patient m is T m , the number of comparison pairs is n, and the survival probability of patient a is The survival probability of patient m is
[0072] Patients who did not receive medical treatment were used as a control group, the risk group was compared with the control group, and the improved performance of the risk group was output as the prognostic performance.
[0073] Furthermore, the method of comparing the prognostic performance with the TNM staging to obtain recurrence data comprises:
[0074] Obtain TNM staging based on patient disease data, and input prognostic performance and TNM staging into the nomination graph model;
[0075] The product limit method was used to draw the survival curves of TNM staging and nomination diagram model, and the prognostic performance was screened according to the survival curve to obtain the recurrence performance;
[0076] Compare the recurrence performance of patients at different times to obtain performance differences, calculate the correlation of performance differences, eliminate performance differences with correlation less than 0.402, and obtain optimal performance differences;
[0077] The preferred performance differences are output as recurrence data.
[0078] Furthermore, a method for constructing a recurrence probability prediction model based on the recurrence data includes:
[0079] Recurrence probability prediction models include random forest algorithm, time series analysis algorithm, and long short-term memory network algorithm;
[0080] The random forest algorithm randomly divided the recurrence data into a training group and a validation group at a ratio of 5:2;
[0081] The time series analysis algorithm obtains the time series variation law through the trend of the training group over time; the long short-term memory network algorithm predicts the recurrence probability through the time series variation law; the validation group is predicted to obtain the predicted recurrence probability, and the parameters of the long short-term memory network algorithm are adjusted according to the error between the predicted recurrence probability and the actual recurrence probability.
[0082] The beneficial effects of the present invention are:
[0083] The present invention is a method for predicting the recurrence probability of a specific disease based on a clustering method. Compared with the prior art, the present invention has the following technical effects:
[0084] The present invention can improve the accuracy of prediction of the recurrence probability of a specific disease by the clustering method through preprocessing, data partitioning, feature identification, permutation and combination, risk stratification, acquisition of prognostic performance, acquisition of recurrence data and model construction steps, thereby improving the accuracy of prediction of the recurrence probability of a specific disease by the clustering method, and optimizing the prediction of the recurrence probability of a specific disease by the clustering method, which can greatly save resources and improve work efficiency, and can realize automatic prediction of the recurrence probability of a specific disease by the clustering method, and perform risk stratification on the prediction of the recurrence probability of a specific disease by the clustering method in real time, which is of great significance for the prediction of the recurrence probability of a specific disease by the clustering method, and can adapt to the prediction of the recurrence probability of a specific disease by clustering methods of different standards and the prediction needs of the recurrence probability of a specific disease by different clustering methods, and has a certain universality. BRIEF DESCRIPTION OF THE DRAWINGS
[0085] Figure 1 A flowchart of the steps of a method for predicting the recurrence probability of a specific disease based on a clustering method of the present invention;
[0086] Figure 2 It is a schematic diagram of the structure of an electronic device in an embodiment of this specification. DETAILED DESCRIPTION
[0087] The present invention is further described below by means of specific embodiments. The illustrative embodiments and descriptions of the present invention are used to explain the present invention but are not intended to limit the present invention.
[0088] The method for predicting the recurrence probability of a specific disease based on a clustering method of the present invention comprises the following steps:
[0089] like Figure 1 As shown, in this embodiment, the following steps are included:
[0090] Collecting disease data of patients at different periods and preprocessing the disease data of patients;
[0091] In the actual evaluation, disease data of NPC patients before, during and after IC treatment were collected;
[0092] Dividing the patient's disease data according to EBV DNA levels and tumor response to obtain subgroup data, and performing feature identification on the subgroup data according to relative risk to obtain temporal disease features;
[0093] In the actual evaluation, the first subgroup data were 2 weeks before the start of IC treatment, the second subgroup data were during IC treatment and within 2 weeks after the completion of IC treatment, the third subgroup data were 3-5 weeks during radiation therapy, and the fourth subgroup data were during radiation therapy and 4-12 weeks after the completion of radiation therapy;
[0094] The temporal disease characteristics were as follows: among all enrolled patients, 52.6% had stage III tumors and 47.4% had stage IV tumors. After IC treatment, more than 70% of patients received CCRT, and less than 30% of patients received IMRT but not CCRT. The 5-year PFS, OS, DMFS, and LRRFS rates in the training group were 68.4%, 78.9%, 73.3%, and 72.6%, respectively, and the PFS, OS, DMFS, and LRRFS rates in the external cohort were 70%, 82.6%, 76.1%, and 77.5%, respectively.
[0095] Arrange and combine the time series disease characteristics to obtain disease manifestation data, and use supervised clustering to perform risk stratification on the disease manifestation data to obtain risk groups;
[0096] In the actual evaluation, there are 7 groups of disease manifestation data;
[0097] Risk stratification was as follows: among 984 patients, cfEBV DNA was undetectable in 79.7% after IC, detected in 87.5% during RT, and detected in 91% during late RT. In terms of tumor regression trajectory, 84.3% of patients achieved CR / PR after IC, 87.4% of patients continued to achieve CR / PR during the mid-RT period, and 93.2% of patients achieved CR / PR after RT, of which 71.8% achieved CR.
[0098] The prognostic performance of the risk group is evaluated by the Concordia Index, and the prognostic performance is compared with the TNM staging to obtain recurrence data;
[0099] In the actual evaluation, the prognostic performance was Concordia index 0.834, 95% IC; the recurrence data were: compared with TNM staging combined with pre-treatment EBV DNA and the nomination graph model, the C index of the response group predicting 5-year PFS was 0.825vs, 0.603vs, 0.626vs, and 0.756vs, respectively;
[0100] Constructing a recurrence probability prediction model according to the recurrence data, inputting the data to be predicted into the recurrence probability prediction model, and outputting a prediction result;
[0101] In practical evaluation, T4 lesions, advanced N stage, primary tumor and metastatic lymph node volumes, and higher pre-treatment cfEBVDNA load were associated with worse treatment outcomes.
[0102] In this embodiment, the method for dividing the patient disease data according to EBV DNA level and tumor response includes:
[0103] The patient's tumor response is obtained through medical imaging and clinical examinations, and the EBV DNA level is obtained by extracting DNA from the patient's blood;
[0104] Calculate the disease factor:
[0105]
[0106] The disease factor at the tth moment is The DNA weight is λ1, the tumor weight is λ2, and the tumor response at the tth moment is The EBV DNA level at the tth moment is Standard tumor response was The standard EBV DNA level is The EBV DNA level at time t-1 is The tumor response at time t-1 is
[0107] When the disease factor is greater than zero and less than 0.27, the patient's disease data is divided into the first subgroup data; when the disease factor is greater than 0.27 and less than 0.48, the patient's disease data is divided into the second subgroup data; when the disease factor is greater than 0.48 and less than 0.77, the patient's disease data is divided into the third subgroup data; when the disease factor is greater than 0.77 and less than 1, the patient's disease data is divided into the fourth subgroup data.
[0108] In this embodiment, the method for obtaining time series disease characteristics by performing feature recognition on the subgroup data according to relative risk includes:
[0109] The edge detection algorithm was used to extract the image features of the subgroup data, and the sliding window technique was used to segment the images in chronological order to obtain segment time series data;
[0110] Calculate the center point of a segment of time series data:
[0111]
[0112] The window size is m, and the time series data of the a+wth segment is d a+w , the center point of the wth segment of time series data is
[0113] Construct a dimension vector to formally represent the center point of the segment time series data. The expression is:
[0114]
[0115] The w-th d value of the i-th window is expressed as The wth segment time series data is d w , the w+1th segment time series data is d w+1 , the time series data of the w+m-1th segment is d w+m-1 ;
[0116] Calculate the similarity between vectors:
[0117]
[0118] The w+sth segment time series data of the i-th window is The w+sth segment time series data of the i+1th window is The center point of the wth segment of the time series data in the i-th window is The center point of the wth segment of the time series data in the i+1th window is The difference between the i-th window segment time series data and the z-th window segment time series data is h i,i+1 , segment timing data and segment timing data The deviation is η i,i+1, similarity capacity parameter is ρ;
[0119] Calculate the change information between vectors:
[0120]
[0121] The segment time series data and segment timing data The change information degree is ε i,i+1 , the number of windows is p, the time series data and segment timing data The change in
[0122] Calculate relative risk:
[0123]
[0124] The relative risk between the i-th window and the z-th window is The scale factor is γ and the heritability coefficient is The initial error value is δ;
[0125] The windows with relative risk absolute values greater than 0.11 were taken as disease windows, and the segment time series data with dissimilarity distances greater than 0.27 within the disease windows were output as disease features.
[0126] In this embodiment, the method of obtaining disease manifestation data by arranging and combining the disease characteristics includes:
[0127] Calculate the association of disease features:
[0128]
[0129] The correlation coefficient between disease feature j and disease feature f is θ jf , the probability of disease feature j and disease feature f appearing at the same time is c(j,f), and the probability of disease feature j appearing is c j , the probability of the characteristic disease f appearing is c f , the first weight is β1, and the second weight is β2;
[0130] According to the degree of association, the disease features are divided into associated feature sets, and the associated feature sets are randomly combined and output as disease manifestation data.
[0131] In this embodiment, the method of using supervised clustering to perform risk stratification on the disease manifestation data to obtain risk groups includes:
[0132] The disease manifestation data is input into a clustering model based on a graph autoencoder, where the clustering model includes an encoder network, a graph encoding network, and an adaptive fusion network;
[0133] K-means clustering was used to perform initial clustering on the disease manifestation data to obtain the initial cluster centers;
[0134] Given the transfer function of the encoder network and the transfer function of the graph encoding network, the expressions are:
[0135]
[0136] The bias vector of the encoder network layer κ is φ κ , the transfer function of the κ-1th layer of the encoder network is G κ-1 , the weight matrix of the encoder network layer κ is F κ , the activation function is The normalized adjacency matrix is Q * , the weight of the κ-1th layer of the graph encoding network is The transfer function of the κth layer of the graph coding network is S κ , the output of the κ-1th layer of the graph encoding network is S κ-1 , the transfer function of the κth layer of the encoder network is G κ ;
[0137] Calculate the propagation function of the first layer network:
[0138]
[0139] The learning rate is χ, and the weight matrix of the κth layer of the adaptive fusion network is The bias vector of the κth layer of the adaptive fusion network is The propagation function of the κth layer of the adaptive fusion network is W κ ;
[0140] Let κ = κ + 1, recalculate the transfer function of the encoder network, the transfer function of the graph encoding network, and calculate the transfer function of the adaptive fusion network:
[0141]
[0142] The transfer function of the κ-1th layer of the graph coding network is W κ-1 , calculate the loss function of the encoder network:
[0143]
[0144] The number of disease manifestation data is P, the output norm function is ‖·‖, the disease manifestation data is Q, and the reconstructed disease manifestation data is V * , the loss function of the computational graph encoding network is:
[0145]
[0146] Calculate the encoder divergence:
[0147]
[0148] The encoder network disease manifestation data k g and the initial cluster center u h The probability distribution of The hth initial cluster center is u h , encoder network disease manifestation data k g and the initial cluster center u h The high confidence distribution of The g-th disease manifestation data is k g , the degrees of freedom are The adjustment factor is σ, and the divergence of the encoder network is L gh ;
[0149] Compute the divergence of the graph encoding network:
[0150]
[0151]
[0152] The heritability coefficient is ζ2, the deviation factor is λ, and the graph encoding network disease expression data k g and the initial cluster center u h The probability distribution of The divergence of the graph coding network is L gh ;
[0153] Calculate the loss function of the clustering model:
[0154]
[0155] The graph weight is α, the divergence weight is μ, and the cluster center is The clustering data is y, and the disease manifestation data is k g and the initial cluster center u h The probability distribution is r gh ;
[0156] Update the weight matrix, bias vector, and learning rate through back-propagation until the maximum number of iterations is reached, otherwise update the transfer function;
[0157] The clustering results are obtained through collaborative training and output as risk groups.
[0158] In this embodiment, the method for evaluating the prognostic performance of the risk group by the Concord Index comprises:
[0159] Machine learning algorithms are used to predict the survival probability and time of the risk group and calculate the concordance index of the risk group:
[0160]
[0161] The concord index is The indicator function is K(·), and the survival time of patient a is T a , the survival time of patient m is T m , the number of comparison pairs is n, and the survival probability of patient a is The survival probability of patient m is
[0162] Patients who did not receive medical treatment were used as a control group, the risk group was compared with the control group, and the improved performance of the risk group was output as the prognostic performance.
[0163] In this embodiment, the method of comparing the prognostic performance with the TNM staging to obtain recurrence data includes:
[0164] Obtain TNM staging based on patient disease data, and input prognostic performance and TNM staging into the nomination graph model;
[0165] The product limit method was used to draw the survival curves of TNM staging and nomination diagram model, and the prognostic performance was screened according to the survival curve to obtain the recurrence performance;
[0166] Compare the recurrence performance of patients at different times to obtain performance differences, calculate the correlation of performance differences, eliminate performance differences with correlation less than 0.402, and obtain optimal performance differences;
[0167] The preferred performance differences are output as recurrence data.
[0168] In this embodiment, the method for constructing a recurrence probability prediction model based on the recurrence data includes:
[0169] Recurrence probability prediction models include random forest algorithm, time series analysis algorithm, and long short-term memory network algorithm;
[0170] The random forest algorithm randomly divided the recurrence data into a training group and a validation group at a ratio of 5:2;
[0171] The time series analysis algorithm obtains the time series variation pattern through the trend of the training group over time;
[0172] The long short-term memory network algorithm predicts the recurrence probability through the time series change law; the prediction is performed on the validation group to obtain the predicted recurrence probability, and the parameters of the long short-term memory network algorithm are adjusted according to the error between the predicted recurrence probability and the actual recurrence probability.
[0173] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for predicting the recurrence probability of a specific disease based on a clustering method, characterized in that: The following steps are involved: Collecting disease data of patients at different periods and preprocessing the disease data of patients; Dividing the patient's disease data according to EBV DNA levels and tumor response to obtain subgroup data, and performing feature identification on the subgroup data according to relative risk to obtain temporal disease features; Arrange and combine the time series disease characteristics to obtain disease manifestation data, and use supervised clustering to perform risk stratification on the disease manifestation data to obtain risk groups; The prognostic performance of the risk group is evaluated by the Concordia Index, and the prognostic performance is compared with the TNM staging to obtain recurrence data; A recurrence probability prediction model is constructed according to the recurrence data, the data to be predicted is input into the recurrence probability prediction model, and a prediction result is output.
2. The method for predicting the recurrence probability of a specific disease based on a clustering method according to claim 1, characterized in that: The method of segmenting the patient disease data according to EBV DNA level and tumor response comprises: The patient's tumor response is obtained through medical imaging and clinical examinations, and the EBV DNA level is obtained by extracting DNA from the patient's blood; Calculate the disease factor: The disease factor at the tth moment is The DNA weight is λ1, the tumor weight is λ2, and the tumor response at the tth moment is l t , the EBV DNA level at the tth moment is Standard tumor response was l o , the standard EBV DNA level is The EBV DNA level at time t-1 is The tumor response at the t-1th moment is l t-1 ; When the disease factor is greater than zero and less than 0.27, the patient's disease data is divided into the first subgroup data; when the disease factor is greater than 0.27 and less than 0.48, the patient's disease data is divided into the second subgroup data; when the disease factor is greater than 0.48 and less than 0.77, the patient's disease data is divided into the third subgroup data; when the disease factor is greater than 0.77 and less than 1, the patient's disease data is divided into the fourth subgroup data.
3. The method for predicting the recurrence probability of a specific disease based on a clustering method according to claim 1, characterized in that: The method for obtaining a temporal disease feature by characterizing the subgroup data according to relative risk comprises: The edge detection algorithm was used to extract the image features of the subgroup data, and the sliding window technique was used to segment the images in chronological order to obtain segment time series data; Calculate the center point of a segment of time series data: The window size is The time series data of the a+wth segment is: The center point of the wth segment of time series data is Construct a dimension vector to formally represent the center point of the segment time series data. The expression is: The wth one in the i-th window The value is expressed as The wth segment timing data is The w+1th segment timing data is No. The time series data for each segment is Calculate the similarity between vectors: The w+sth segment time series data of the i-th window is The w+sth segment time series data of the i+1th window is The center point of the wth segment of the time series data in the i-th window is The center point of the wth segment of the time series data in the i+1th window is The difference between the i-th window segment time series data and the z-th window segment time series data is h i,i+1 , segment timing data and segment timing data The deviation is η i,i+1 , similarity capacity parameter is ρ; Calculate the change information between vectors: The segment time series data and segment timing data The change information degree is ε i,i+1 , the number of windows is p, the time series data and segment timing data The change in Calculate relative risk: The relative risk between the i-th window and the z-th window is The scaling factor is γ and the heritability coefficient is The initial error value is δ; The windows with relative risk absolute values greater than 0.11 were taken as disease windows, and the segment time series data with dissimilarity distances greater than 0.27 within the disease windows were output as disease features.
4. The method for predicting the recurrence probability of a specific disease based on a clustering method according to claim 1, characterized in that: The method of obtaining disease manifestation data by arranging and combining the disease characteristics comprises: Calculate the association of disease features: The correlation coefficient between disease feature j and disease feature f is θ jf , the probability of disease feature j and disease feature f appearing at the same time is c(j,f), and the probability of disease feature j appearing is c j , the probability of the characteristic disease f appearing is c f , the first weight is β1, and the second weight is β2; According to the degree of association, the disease features are divided into associated feature sets, and the associated feature sets are randomly combined and output as disease manifestation data.
5. The method for predicting the recurrence probability of a specific disease based on a clustering method according to claim 1, characterized in that: The method of using supervised clustering to perform risk stratification on the disease manifestation data to obtain risk groups comprises: The disease manifestation data is input into a clustering model based on a graph autoencoder, where the clustering model includes an encoder network, a graph encoding network, and an adaptive fusion network; K-means clustering was used to perform initial clustering on the disease manifestation data to obtain the initial cluster centers; Given the transfer function of the encoder network and the transfer function of the graph encoding network, the expressions are: The bias vector of the encoder network layer κ is φ κ , the transfer function of the κ-1th layer of the encoder network is G κ-1 , the weight matrix of the encoder network layer κ is F κ , the activation function is The normalized adjacency matrix is Q * , the weight of the κ-1th layer of the graph encoding network is The transfer function of the κth layer of the graph coding network is S κ , the output of the κ-1th layer of the graph encoding network is S κ-1 , the transfer function of the encoder network layer κ is G κ ; Calculate the propagation function of the first layer network: The learning rate is χ, and the weight matrix of the κth layer of the adaptive fusion network is The bias vector of the κth layer of the adaptive fusion network is The propagation function of the κth layer of the adaptive fusion network is W κ ; Let κ = κ + 1, recalculate the transfer function of the encoder network, the transfer function of the graph encoding network, and calculate the transfer function of the adaptive fusion network: The transfer function of the κ-1th layer of the graph coding network is W κ-1 , calculate the loss function of the encoder network: The number of disease manifestation data is P, the output norm function is ‖p‖, the disease manifestation data is Q, and the reconstructed disease manifestation data is V *φ , the loss function of the computational graph encoding network is: Calculate the encoder divergence: The encoder network disease manifestation data k g and the initial cluster center u h The probability distribution of The hth initial cluster center is u h , encoder network disease manifestation data k g and the initial cluster center u h The high confidence distribution of The g-th disease manifestation data is k g , the degrees of freedom are The adjustment factor is σ, and the divergence of the encoder network is L gh ; Compute the divergence of the graph encoding network: The heritability coefficient is ζ2, the deviation factor is λ, and the graph encoding network disease expression data k g and the initial cluster center u h The probability distribution of The divergence of the graph coding network is L gh ; Calculate the loss function of the clustering model: The graph weight is α, the divergence weight is μ, and the cluster center is The clustering data is y, and the disease manifestation data is k g and the initial cluster center u h The probability distribution is r gh ; Update the weight matrix, bias vector, and learning rate through back-propagation until the maximum number of iterations is reached, otherwise update the transfer function; The clustering results are obtained through collaborative training and output as risk groups.
6. The method for predicting the recurrence probability of a specific disease based on a clustering method according to claim 1, characterized in that: The method for evaluating the prognostic performance of the risk group by the Concordia Index comprises: Machine learning algorithms are used to predict the survival probability and time of the risk group and calculate the concordance index of the risk group: The concord index is The indicator function is K(·), and the patient The survival time is The survival time of patient m is T m , the number of comparison pairs is n, and the patient The survival probability is The survival probability of patient m is Patients who did not receive medical treatment were used as a control group, the risk group was compared with the control group, and the improved performance of the risk group was output as the prognostic performance.
7. The method for predicting the recurrence probability of a specific disease based on a clustering method according to claim 1, characterized in that: The method of comparing the prognostic performance with the TNM staging to obtain recurrence data comprises: Obtain TNM staging based on patient disease data, and input prognostic performance and TNM staging into the nomination graph model; The product limit method was used to draw the survival curves of TNM staging and nomination diagram model, and the prognostic performance was screened according to the survival curve to obtain the recurrence performance; Compare the recurrence performance of patients at different times to obtain performance differences, calculate the correlation of performance differences, eliminate performance differences with correlation less than 0.402, and obtain optimal performance differences; The preferred performance differences are output as recurrence data.
8. The method for predicting the recurrence probability of a specific disease based on a clustering method according to claim 1, characterized in that: The method for constructing a recurrence probability prediction model according to the recurrence data comprises: Recurrence probability prediction models include random forest algorithm, time series analysis algorithm, and long short-term memory network algorithm; The random forest algorithm randomly divided the recurrence data into a training group and a validation group at a ratio of 5:2; The time series analysis algorithm obtains the time series variation pattern through the trend of the training group over time; The long short-term memory network algorithm predicts the recurrence probability through the time series change law; the prediction is performed on the validation group to obtain the predicted recurrence probability, and the parameters of the long short-term memory network algorithm are adjusted according to the error between the predicted recurrence probability and the actual recurrence probability.
Citation Information
Patent Citations
Approximation spectral clustering algorithm based method for predicting cancer metastasis and recurrence
CN105243300A
Cerebral malignant tumor patient survival prediction method and system, terminal and storage medium
CN114171199A
Nasopharynx cancer patient survival prediction model, construction method, equipment and storage medium
CN114613502A
Method for constructing disease risk prediction model of slow patient group based on graph auto-encoder
CN114783608A
Disease auxiliary decision-making system based on personalized state space progress model
CN115019960A
Cited By
Data management method and system of Internet of Things equipment based on big data
CN119917567A
Chronic patient symptom management method and system based on symptom network analysis
CN120260906A
A symptom management method and system for chronic patients based on symptom network analysis
CN120260906B
Lung adenocarcinoma recurrence prediction method and system based on multi-omics data analysis
CN120853876A
A lung adenocarcinoma recurrence prediction method and system based on multi-omics data analysis
CN120853876B
